Skip to main content Accessibility help
×
Hostname: page-component-84b7d79bbc-7nlkj Total loading time: 0 Render date: 2024-07-26T01:25:14.385Z Has data issue: false hasContentIssue false

1 - Stem cell defect in aplastic anemia

from Part I - Pathophysiology of acquired aplastic anemia

Published online by Cambridge University Press:  18 August 2009

Judith C.W. Marsh
Affiliation:
St George's Hospital, London
Nydia G. Testa
Affiliation:
University of Manchester
Hubert Schrezenmeier
Affiliation:
Freie Universität Berlin
Andrea Bacigalupo
Affiliation:
Ospedale San Martino, Genoa
Get access

Summary

Normal stem cells

Definition

The need to continuously replace mature cells in the blood requires the production of about 1011 new cells daily in a normal adult, and even more in response to hemopoietic stress. It is known that all these cells are derived from a common ancestor population, the pluripotential stem cells (Lajtha, 1983). The usually accepted definition of stem cells is based on three characteristics: first, their marked capacity for proliferation, as just illustrated, and, second, their potential to undergo differentiation to produce all the lymphohemopoietic mature cell types (Metcalf, 1988). Third, and classically, stem cells are also defined by their reported capacity for self-renewal, i.e., the capacity to generate new stem cells, with the implication that they are able to regenerate their own population (Lajtha, 1983; Metcalf, 1988). As we will discuss later, it is mainly this latter concept that has to be discussed in the context of aplastic anemia (AA).

Regulation

Stem cells comprise only a small minority, between 0.01 and 0.05%, of the total cells found in bone marrow. At least 95% of the hemopoietic cells fall into morphologically recognizable types. The remaining, with nonspecific morphological features, require phenotypic and functional characterization. They encompass not only the stem cells but also their immediate progeny, the progenitor cells which were first characterized by their ability to develop in vitro in response to the colony-stimulating factors (CSF) (Metcalf, 1988).

Type
Chapter
Information
Aplastic Anemia
Pathophysiology and Treatment
, pp. 3 - 20
Publisher: Cambridge University Press
Print publication year: 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×